Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pivotal trial begins for FK-228 for CTCL

March 4, 2005

Enrollment open in phase II study of PTK/ZK in NSCLC

March 4, 2005

BioPro takes Asia-Pacific rights to Vantas

March 4, 2005

Cytotoxic effects of telomerase inhibition with BIBR-1532 in leukemia cells

March 4, 2005

AstraZeneca claims novel Aurora kinase inhibitors for the treatment of cancer

March 3, 2005

OSI-930 enters clinical development

March 3, 2005

Second phase I study for MPC-6827

March 3, 2005

Second mutation in EGFR kinase domain confers resistance to gefitinib or erlotinib

March 2, 2005

Intarcia begins phase III study for advanced breast cancer

March 2, 2005

Sosei seeks Japanese approval for SOT-375

March 2, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....